David Smil

6PUBLICATIONS
31CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designMolecular targetsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 18, 2024
Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2.

Václav Němec, Marek Remeš, Petr Beňovský

|Mar 18, 2024
Discovery of Conformationally Constrained ALK2 Inhibitors.

Héctor González-Álvarez, Deeba Ensan, Tao Xin

|May 31, 2021
Leveraging Open Science Drug Development for PET: Preliminary Neuroimaging of 11C-Labeled ALK2 Inhibitors.

Emily Murrell, Junchao Tong, David Smil

|Aug 14, 2020
Leveraging an Open Science Drug Discovery Model to Develop CNS-Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma.

David Smil, Jong Fu Wong, Eleanor P Williams

|May 06, 2020
Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma.

Deeba Ensan, David Smil, Carlos A Zepeda-Velázquez

|Jan 04, 2019
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling.

Sebastian Scheer, Suzanne Ackloo, Tiago S Medina

Pageof 1

Frequent Collaborators

3 joint publications

Alex N Bullock

3 joint publications

Rima Al-Awar

2 joint publications

Julien Cros

2 joint publications

Methvin B Isaac